Delgocitinib

Our Delgocitinib intermediates are developed to meet stringent global standards for Active Pharmaceutical Ingredients (APIs). Manufactured using advanced synthesis routes and precise quality control, they enable efficient, high-yield production of Delgocitinib. With scalable and reproducible processes, we ensure consistent purity and stability from lab-scale development to commercial manufacturing. Each intermediate is optimized for process efficiency, regulatory compliance, and reliable performance in formulation. Partnering with SSPharma gives you access to high-quality Delgocitinib intermediates that support faster development cycles, robust supply chains, and seamless transition from R&D to large-scale production.

Delgocitinib - Intermediate

Intermediate image

Name of Intermediate: tert-butyl (3S)-4-(7-bromo-6-chloro-2,8-difluoroquinazolin-4-yl)-3-methylpiperazine-1-carboxylate

Name of API: Delgocitinib

CAS No: 2417918-75-1